2016

High Prostate Cancer Risk Linked to Inherited Mutations in DNA-repair Genes.

Mutations in DNA-repair genes, including the breast cancer genes BRCA1 and BRCA2, are involved in an inherited high risk of prostate cancer and, potentially, the risk of an aggressive cancer, according to researchers at Fred Hutchinson Cancer Research Center and the University of Washington. The study, “Inherited DNA -Repair Gene Mutations in Men with Metastatic Prostate Cancer” published in The more »

Higher Vitamin D Levels Linked with Improved Prostate Cancer Survival

In an article published in the journal Cancer Epidemiology, Biomarkers & Prevention (2016, Jan. 25), researchers at the National Cancer Institute (NCI) of the National Institutes of Health (NIH)  document an association between higher serum levels of vitamin D and an increased chance of surviving prostate cancer. The current investigation included 1,000 participants in the more »

Bladder Cancer and Colorectal Cancer Risks Higher Following Prostate Radiotherapy

Prostate cancer patients who undergo radiation treatment, especially brachytherapy, are at increased relative risk of bladder cancer according to new study findings presented at the American Urological Association 2016 annual meeting by researchers from Albert Einstein College of Medicine in New York. This increased relative risk occurs predominantly after 10 years. Bladder tumors found in more »

A Video Conference on Treatment Options for Localized Prostate Cancer

Zero, the Project to End Prostate Cancer, is sponsoring a videocast on July 13th from 3-4 PM.  The video conference will discuss various treatment options for treating localized prostate cancer. These include surgery, external radiation, brachytherapy, high-intensity focused ultrasound (HIFU), cryotherapy, active surveillance and other options. The speakers are Dr. Kelvin Moses from Vanderbilt University more »

An Update on the Effect of Pomegranate on Prostate Cancer

An April 4th, 2011 website post described two studies from Johns Hopkins and UCLA which concluded that pomegranate extract increased PSA doubling time (PSADT) in men with prostate cancer. Recently, the National Cancer Institute (NCI) has updated its information from human studies of pomegranate extract. In a study reported in 2006, researchers observed the effects more »

The FDA Approves a New Diagnostic Imaging Agent (Axumin) to Detect Recurrent Prostate Cancer.

Several positron emission tomography (PET) scans (including C-11 choline and acetate PET scans) exist whose purpose is to detect the location of recurrent prostate cancer when the PSA is at low levels. Within the last few days, the U.S. Food and Drug Administration approved another scan using an injected radioactive agent called Axumin. The following more »

Prostate Cancer and Bone Metastases; What You Should Know.

In a very informative seven minute video clip recently posted on Prostate Cancer News Today, Dr. Alicia K. Morgans, an Assistant Professor of Medicine in the subject of hematology and oncology, at the Vanderbilt-Ingram Cancer Center discusses prostate cancer and bone metastasis. She discusses what these diseases entail, how they spread, where in the body they spread, more »

An Excellent Reference on Prostate Cancer Clinical Trials

Prostate Cancer News Today is a weekly e mail from Bayer Healthcare that contains 3-4 articles referencing various aspects of prostate cancer. An e mail received May 16th, 2016 contained an article called “Finding Out About Prostate Cancer Clinical Trials.” The article was one of the best references I have seen to provide information about more »

Low Vitamin D Levels May Signal More Aggressive Prostate Cancer But Don’t Expect Supplements to Ward Off Fast-Growing Tumors.

A Northwestern University study of 190 men of median age 64 having their prostate removed found those with low vitamin D levels were more likely to have rapidly growing tumors than those with normal levels of the “sunshine” vitamin.  The study was published on-line in the Journal of Clinical Oncology. The researchers found that nearly more »

Hormone Therapy for Prostate Cancer Linked to Depression and a Personal Note of Encouragement.

A large study (see the Cancer Network Oncology link) from Harvard Medical School and Brigham and Women’s Hospital in Boston suggests that men receiving testosterone-suppressing (hormone) therapy (ADT) for prostate cancer may be at increased risk of developing depression. The findings, published online April 11th in the Journal of Clinical Oncology, are based on Medicare more »

God Reinforces His Promises!

Since I personally have recurrent but asymptomatic prostate cancer, I have my PSA checked every four months.  Thinking back to similar experiences over the past twenty years, this regular PSA testing usually was accompanied by some degree of anxiety, fear and pleas to God that the results would be positive.  While some degree of apprehension more »